aluates Reports

$ 0.0

Automative

Global Gynecological Cancer Diagnostics Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-30P10282

Global Gynecological Cancer Diagnostics Market Research Report 2022

BUY CHAPTERS

Global Gynecological Cancer Diagnostics Market Research Report 2024

Code: QYRE-Auto-30P10282

Report

June 2024

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abramson Cancer Center

Fujirebio

Agilent Technologies Inc

ARUP Laboratories

CENTOGENE

F Hoffmann La Roche Ltd

Fulgent Genetics Inc

Invitae Corporation

Myriad Genetics Inc

BGI Group

UT Southwestern

Northwestern Medicine

Sysmex Europe SE

Premier Health

Gynecological Cancer Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gynecological Cancer Diagnostics Market

The global Gynecological Cancer Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gynecological Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gynecological Cancer Diagnostics.

Report Scope

The Gynecological Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gynecological Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gynecological Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gynecological Cancer Diagnostics Market Report

Report Metric	Details
Report Name	Gynecological Cancer Diagnostics Market
CAGR	5%
Segment by Type	Genetic Counseling Test Cancer Risk Test Kits Test
Segment by Application	Gestational Trophoblastic Disease Diagnostics Endometrial Cancer Diagnostics Peritoneal Cancer Diagnostics Cervical Cancer Diagnostics Ovarian Cancer Diagnostics Vaginal Cancer Diagnostics Uterine Cancer Diagnostics Vulvar Cancer Diagnostics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	UT Southwestern, Abramson Cancer Center, Northwestern Medicine, Sysmex Europe SE, Fujirebio, Premier Health, Agilent Technologies, Inc, ARUP Laboratories, CENTOGENE, F. Hoffmann-La Roche Ltd, Fulgent Genetics, Inc, Invitae Corporation, Myriad Genetics, Inc, BGI Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gynecological Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gynecological Cancer Diagnostics Market report?

Ans: The main players in the Gynecological Cancer Diagnostics Market are UT Southwestern, Abramson Cancer Center, Northwestern Medicine, Sysmex Europe SE, Fujirebio, Premier Health, Agilent Technologies, Inc, ARUP Laboratories, CENTOGENE, F. Hoffmann-La Roche Ltd, Fulgent Genetics, Inc, Invitae Corporation, Myriad Genetics, Inc, BGI Group

What are the Application segmentation covered in the Gynecological Cancer Diagnostics Market report?

Ans: The Applications covered in the Gynecological Cancer Diagnostics Market report are Gestational Trophoblastic Disease Diagnostics, Endometrial Cancer Diagnostics, Peritoneal Cancer Diagnostics, Cervical Cancer Diagnostics, Ovarian Cancer Diagnostics, Vaginal Cancer Diagnostics, Uterine Cancer Diagnostics, Vulvar Cancer Diagnostics

What are the Type segmentation covered in the Gynecological Cancer Diagnostics Market report?

Ans: The Types covered in the Gynecological Cancer Diagnostics Market report are Genetic Counseling Test, Cancer Risk Test, Kits Test

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gynecological Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Genetic Counseling Test

1.2.3 Cancer Risk Test

1.2.4 Kits Test

1.3 Market by Application

1.3.1 Global Gynecological Cancer Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Gestational Trophoblastic Disease Diagnostics

1.3.3 Endometrial Cancer Diagnostics

1.3.4 Peritoneal Cancer Diagnostics

1.3.5 Cervical Cancer Diagnostics

1.3.6 Ovarian Cancer Diagnostics

1.3.7 Vaginal Cancer Diagnostics

1.3.8 Uterine Cancer Diagnostics

1.3.9 Vulvar Cancer Diagnostics

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gynecological Cancer Diagnostics Market Perspective (2019-2030)

2.2 Gynecological Cancer Diagnostics Growth Trends by Region

2.2.1 Global Gynecological Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Gynecological Cancer Diagnostics Historic Market Size by Region (2019-2024)

2.2.3 Gynecological Cancer Diagnostics Forecasted Market Size by Region (2025-2030)

2.3 Gynecological Cancer Diagnostics Market Dynamics

2.3.1 Gynecological Cancer Diagnostics Industry Trends

2.3.2 Gynecological Cancer Diagnostics Market Drivers

2.3.3 Gynecological Cancer Diagnostics Market Challenges

2.3.4 Gynecological Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gynecological Cancer Diagnostics Players by Revenue

3.1.1 Global Top Gynecological Cancer Diagnostics Players by Revenue (2019-2024)

3.1.2 Global Gynecological Cancer Diagnostics Revenue Market Share by Players (2019-2024)

3.2 Global Gynecological Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Gynecological Cancer Diagnostics Revenue

3.4 Global Gynecological Cancer Diagnostics Market Concentration Ratio

3.4.1 Global Gynecological Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gynecological Cancer Diagnostics Revenue in 2023

3.5 Gynecological Cancer Diagnostics Key Players Head office and Area Served

3.6 Key Players Gynecological Cancer Diagnostics Product Solution and Service

3.7 Date of Enter into Gynecological Cancer Diagnostics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Gynecological Cancer Diagnostics Breakdown Data by Type

4.1 Global Gynecological Cancer Diagnostics Historic Market Size by Type (2019-2024)

4.2 Global Gynecological Cancer Diagnostics Forecasted Market Size by Type (2025-2030)

5 Gynecological Cancer Diagnostics Breakdown Data by Application

5.1 Global Gynecological Cancer Diagnostics Historic Market Size by Application (2019-2024)

5.2 Global Gynecological Cancer Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Gynecological Cancer Diagnostics Market Size (2019-2030)

6.2 North America Gynecological Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Gynecological Cancer Diagnostics Market Size by Country (2019-2024)

6.4 North America Gynecological Cancer Diagnostics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gynecological Cancer Diagnostics Market Size (2019-2030)

7.2 Europe Gynecological Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Gynecological Cancer Diagnostics Market Size by Country (2019-2024)

7.4 Europe Gynecological Cancer Diagnostics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gynecological Cancer Diagnostics Market Size (2019-2030)

8.2 Asia-Pacific Gynecological Cancer Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Region (2019-2024)

8.4 Asia-Pacific Gynecological Cancer Diagnostics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gynecological Cancer Diagnostics Market Size (2019-2030)

9.2 Latin America Gynecological Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Gynecological Cancer Diagnostics Market Size by Country (2019-2024)

9.4 Latin America Gynecological Cancer Diagnostics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gynecological Cancer Diagnostics Market Size (2019-2030)

10.2 Middle East & Africa Gynecological Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Country (2019-2024)

10.4 Middle East & Africa Gynecological Cancer Diagnostics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 UT Southwestern

11.1.1 UT Southwestern Company Detail

11.1.2 UT Southwestern Business Overview

11.1.3 UT Southwestern Gynecological Cancer Diagnostics Introduction

11.1.4 UT Southwestern Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.1.5 UT Southwestern Recent Development

11.2 Abramson Cancer Center

11.2.1 Abramson Cancer Center Company Detail

11.2.2 Abramson Cancer Center Business Overview

11.2.3 Abramson Cancer Center Gynecological Cancer Diagnostics Introduction

11.2.4 Abramson Cancer Center Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.2.5 Abramson Cancer Center Recent Development

11.3 Northwestern Medicine

11.3.1 Northwestern Medicine Company Detail

11.3.2 Northwestern Medicine Business Overview

11.3.3 Northwestern Medicine Gynecological Cancer Diagnostics Introduction

11.3.4 Northwestern Medicine Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.3.5 Northwestern Medicine Recent Development

11.4 Sysmex Europe SE

11.4.1 Sysmex Europe SE Company Detail

11.4.2 Sysmex Europe SE Business Overview

11.4.3 Sysmex Europe SE Gynecological Cancer Diagnostics Introduction

11.4.4 Sysmex Europe SE Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.4.5 Sysmex Europe SE Recent Development

11.5 Fujirebio

11.5.1 Fujirebio Company Detail

11.5.2 Fujirebio Business Overview

11.5.3 Fujirebio Gynecological Cancer Diagnostics Introduction

11.5.4 Fujirebio Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.5.5 Fujirebio Recent Development

11.6 Premier Health

11.6.1 Premier Health Company Detail

11.6.2 Premier Health Business Overview

11.6.3 Premier Health Gynecological Cancer Diagnostics Introduction

11.6.4 Premier Health Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.6.5 Premier Health Recent Development

11.7 Agilent Technologies, Inc

11.7.1 Agilent Technologies, Inc Company Detail

11.7.2 Agilent Technologies, Inc Business Overview

11.7.3 Agilent Technologies, Inc Gynecological Cancer Diagnostics Introduction

11.7.4 Agilent Technologies, Inc Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.7.5 Agilent Technologies, Inc Recent Development

11.8 ARUP Laboratories

11.8.1 ARUP Laboratories Company Detail

11.8.2 ARUP Laboratories Business Overview

11.8.3 ARUP Laboratories Gynecological Cancer Diagnostics Introduction

11.8.4 ARUP Laboratories Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.8.5 ARUP Laboratories Recent Development

11.9 CENTOGENE

11.9.1 CENTOGENE Company Detail

11.9.2 CENTOGENE Business Overview

11.9.3 CENTOGENE Gynecological Cancer Diagnostics Introduction

11.9.4 CENTOGENE Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.9.5 CENTOGENE Recent Development

11.10 F. Hoffmann-La Roche Ltd

11.10.1 F. Hoffmann-La Roche Ltd Company Detail

11.10.2 F. Hoffmann-La Roche Ltd Business Overview

11.10.3 F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Introduction

11.10.4 F. Hoffmann-La Roche Ltd Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.10.5 F. Hoffmann-La Roche Ltd Recent Development

11.11 Fulgent Genetics, Inc

11.11.1 Fulgent Genetics, Inc Company Detail

11.11.2 Fulgent Genetics, Inc Business Overview

11.11.3 Fulgent Genetics, Inc Gynecological Cancer Diagnostics Introduction

11.11.4 Fulgent Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.11.5 Fulgent Genetics, Inc Recent Development

11.12 Invitae Corporation

11.12.1 Invitae Corporation Company Detail

11.12.2 Invitae Corporation Business Overview

11.12.3 Invitae Corporation Gynecological Cancer Diagnostics Introduction

11.12.4 Invitae Corporation Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.12.5 Invitae Corporation Recent Development

11.13 Myriad Genetics, Inc

11.13.1 Myriad Genetics, Inc Company Detail

11.13.2 Myriad Genetics, Inc Business Overview

11.13.3 Myriad Genetics, Inc Gynecological Cancer Diagnostics Introduction

11.13.4 Myriad Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.13.5 Myriad Genetics, Inc Recent Development

11.14 BGI Group

11.14.1 BGI Group Company Detail

11.14.2 BGI Group Business Overview

11.14.3 BGI Group Gynecological Cancer Diagnostics Introduction

11.14.4 BGI Group Revenue in Gynecological Cancer Diagnostics Business (2019-2024)

11.14.5 BGI Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Abramson Cancer Center

Fujirebio

Agilent Technologies Inc

ARUP Laboratories

CENTOGENE

F Hoffmann La Roche Ltd

Fulgent Genetics Inc

Invitae Corporation

Myriad Genetics Inc

BGI Group

UT Southwestern

Northwestern Medicine

Sysmex Europe SE

Premier Health

List of Tables

Table 1. Global Gynecological Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Genetic Counseling Test

Table 3. Key Players of Cancer Risk Test

Table 4. Key Players of Kits Test

Table 5. Global Gynecological Cancer Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Gynecological Cancer Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Gynecological Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Gynecological Cancer Diagnostics Market Share by Region (2019-2024)

Table 9. Global Gynecological Cancer Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Gynecological Cancer Diagnostics Market Share by Region (2025-2030)

Table 11. Gynecological Cancer Diagnostics Market Trends

Table 12. Gynecological Cancer Diagnostics Market Drivers

Table 13. Gynecological Cancer Diagnostics Market Challenges

Table 14. Gynecological Cancer Diagnostics Market Restraints

Table 15. Global Gynecological Cancer Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Gynecological Cancer Diagnostics Market Share by Players (2019-2024)

Table 17. Global Top Gynecological Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gynecological Cancer Diagnostics as of 2023)

Table 18. Ranking of Global Top Gynecological Cancer Diagnostics Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Gynecological Cancer Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Gynecological Cancer Diagnostics Product Solution and Service

Table 22. Date of Enter into Gynecological Cancer Diagnostics Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Gynecological Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Gynecological Cancer Diagnostics Revenue Market Share by Type (2019-2024)

Table 26. Global Gynecological Cancer Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Gynecological Cancer Diagnostics Revenue Market Share by Type (2025-2030)

Table 28. Global Gynecological Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Gynecological Cancer Diagnostics Revenue Market Share by Application (2019-2024)

Table 30. Global Gynecological Cancer Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Gynecological Cancer Diagnostics Revenue Market Share by Application (2025-2030)

Table 32. North America Gynecological Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Gynecological Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Gynecological Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Gynecological Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Gynecological Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Gynecological Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Gynecological Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Gynecological Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Gynecological Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Gynecological Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Gynecological Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Gynecological Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Gynecological Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Gynecological Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Gynecological Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 47. UT Southwestern Company Detail

Table 48. UT Southwestern Business Overview

Table 49. UT Southwestern Gynecological Cancer Diagnostics Product

Table 50. UT Southwestern Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 51. UT Southwestern Recent Development

Table 52. Abramson Cancer Center Company Detail

Table 53. Abramson Cancer Center Business Overview

Table 54. Abramson Cancer Center Gynecological Cancer Diagnostics Product

Table 55. Abramson Cancer Center Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 56. Abramson Cancer Center Recent Development

Table 57. Northwestern Medicine Company Detail

Table 58. Northwestern Medicine Business Overview

Table 59. Northwestern Medicine Gynecological Cancer Diagnostics Product

Table 60. Northwestern Medicine Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 61. Northwestern Medicine Recent Development

Table 62. Sysmex Europe SE Company Detail

Table 63. Sysmex Europe SE Business Overview

Table 64. Sysmex Europe SE Gynecological Cancer Diagnostics Product

Table 65. Sysmex Europe SE Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 66. Sysmex Europe SE Recent Development

Table 67. Fujirebio Company Detail

Table 68. Fujirebio Business Overview

Table 69. Fujirebio Gynecological Cancer Diagnostics Product

Table 70. Fujirebio Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 71. Fujirebio Recent Development

Table 72. Premier Health Company Detail

Table 73. Premier Health Business Overview

Table 74. Premier Health Gynecological Cancer Diagnostics Product

Table 75. Premier Health Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 76. Premier Health Recent Development

Table 77. Agilent Technologies, Inc Company Detail

Table 78. Agilent Technologies, Inc Business Overview

Table 79. Agilent Technologies, Inc Gynecological Cancer Diagnostics Product

Table 80. Agilent Technologies, Inc Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 81. Agilent Technologies, Inc Recent Development

Table 82. ARUP Laboratories Company Detail

Table 83. ARUP Laboratories Business Overview

Table 84. ARUP Laboratories Gynecological Cancer Diagnostics Product

Table 85. ARUP Laboratories Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 86. ARUP Laboratories Recent Development

Table 87. CENTOGENE Company Detail

Table 88. CENTOGENE Business Overview

Table 89. CENTOGENE Gynecological Cancer Diagnostics Product

Table 90. CENTOGENE Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 91. CENTOGENE Recent Development

Table 92. F. Hoffmann-La Roche Ltd Company Detail

Table 93. F. Hoffmann-La Roche Ltd Business Overview

Table 94. F. Hoffmann-La Roche Ltd Gynecological Cancer Diagnostics Product

Table 95. F. Hoffmann-La Roche Ltd Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 96. F. Hoffmann-La Roche Ltd Recent Development

Table 97. Fulgent Genetics, Inc Company Detail

Table 98. Fulgent Genetics, Inc Business Overview

Table 99. Fulgent Genetics, Inc Gynecological Cancer Diagnostics Product

Table 100. Fulgent Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 101. Fulgent Genetics, Inc Recent Development

Table 102. Invitae Corporation Company Detail

Table 103. Invitae Corporation Business Overview

Table 104. Invitae Corporation Gynecological Cancer Diagnostics Product

Table 105. Invitae Corporation Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 106. Invitae Corporation Recent Development

Table 107. Myriad Genetics, Inc Company Detail

Table 108. Myriad Genetics, Inc Business Overview

Table 109. Myriad Genetics, Inc Gynecological Cancer Diagnostics Product

Table 110. Myriad Genetics, Inc Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 111. Myriad Genetics, Inc Recent Development

Table 112. BGI Group Company Detail

Table 113. BGI Group Business Overview

Table 114. BGI Group Gynecological Cancer Diagnostics Product

Table 115. BGI Group Revenue in Gynecological Cancer Diagnostics Business (2019-2024) & (US$ Million)

Table 116. BGI Group Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gynecological Cancer Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Gynecological Cancer Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Genetic Counseling Test Features

Figure 4. Cancer Risk Test Features

Figure 5. Kits Test Features

Figure 6. Global Gynecological Cancer Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Gynecological Cancer Diagnostics Market Share by Application: 2023 VS 2030

Figure 8. Gestational Trophoblastic Disease Diagnostics Case Studies

Figure 9. Endometrial Cancer Diagnostics Case Studies

Figure 10. Peritoneal Cancer Diagnostics Case Studies

Figure 11. Cervical Cancer Diagnostics Case Studies

Figure 12. Ovarian Cancer Diagnostics Case Studies

Figure 13. Vaginal Cancer Diagnostics Case Studies

Figure 14. Uterine Cancer Diagnostics Case Studies

Figure 15. Vulvar Cancer Diagnostics Case Studies

Figure 16. Gynecological Cancer Diagnostics Report Years Considered

Figure 17. Global Gynecological Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Gynecological Cancer Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Gynecological Cancer Diagnostics Market Share by Region: 2023 VS 2030

Figure 20. Global Gynecological Cancer Diagnostics Market Share by Players in 2023

Figure 21. Global Top Gynecological Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gynecological Cancer Diagnostics as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Gynecological Cancer Diagnostics Revenue in 2023

Figure 23. North America Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Gynecological Cancer Diagnostics Market Share by Country (2019-2030)

Figure 25. United States Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Gynecological Cancer Diagnostics Market Share by Country (2019-2030)

Figure 29. Germany Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Gynecological Cancer Diagnostics Market Share by Region (2019-2030)

Figure 37. China Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Japan Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. South Korea Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. India Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Australia Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Gynecological Cancer Diagnostics Market Share by Country (2019-2030)

Figure 45. Mexico Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Brazil Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Gynecological Cancer Diagnostics Market Share by Country (2019-2030)

Figure 49. Turkey Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Gynecological Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. UT Southwestern Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 52. Abramson Cancer Center Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 53. Northwestern Medicine Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 54. Sysmex Europe SE Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 55. Fujirebio Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 56. Premier Health Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 57. Agilent Technologies, Inc Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 58. ARUP Laboratories Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 59. CENTOGENE Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 60. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 61. Fulgent Genetics, Inc Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 62. Invitae Corporation Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 63. Myriad Genetics, Inc Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 64. BGI Group Revenue Growth Rate in Gynecological Cancer Diagnostics Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions